rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Mark T. Frost

Chief Financial Officer

Company insider

Files Form 4 as: Chief Financial Officer, Harvard Bioscience; Chief Financial Officer, Fathom Digital Manufacturing; SVP, CFO & Treasurer, Analogic; EVP and CFO, AngioDynamics; Chief Financial Officer, Albany Molecular Research.

In numbers

Trades disclosed
70
Buys
4
Sells
1
Bought
$129K
Sold
$6,806
Companies
5
Companies where not an officer
0
First trade
5 May 2006
Last trade
20 Mar 2026
Last filed
1 Apr 2026

Companies traded

Where they are an officer
HBIO Harvard BioscienceOfficer · Life-science tools · last 20 Mar 20261 buy · 0 sells
Fathom Digital ManufacturingDirector, Officer · last 4 Apr 20240 buys · 1 sell
AnalogicOfficer · last 5 Dec 20160 buys · 0 sells
ANGO AngioDynamicsOfficer · Medical Devices · last 6 Aug 20150 buys · 0 sells
Albany Molecular ResearchOfficer · last 14 Sep 20123 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
01Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
20 Mar 2026filed 1 Apr 2026HBIO Harvard BioscienceLife-science toolsSEC FORM 4 Code A—30,000 at $0.00filing
20 Mar 2026filed 1 Apr 2026HBIO Harvard BioscienceLife-science toolsSEC FORM 4 Code A—30,000 at $0.00filing
16 Mar 2026filed 1 Apr 2026HBIO Harvard BioscienceLife-science toolsSEC FORM 4 Bought$25K5,000 at $5.00filing
16 Mar 2026filed 1 Apr 2026HBIO Harvard BioscienceLife-science toolsSEC FORM 4 Bought$25K5,000 at $5.00filing
12 May 2025filed 14 May 2025HBIO Harvard BioscienceLife-science toolsSEC FORM 4 Code A—100,000 at $0.00filing
4 Apr 2024filed 22 Apr 2024Fathom Digital ManufacturingSEC FORM 4 Code F$6,1881,369 at $4.52filing
26 Feb 2024filed 27 Feb 2024Fathom Digital ManufacturingSEC FORM 4 Code F$857197 at $4.35filing
3 Apr 2023filed 11 May 2023Fathom Digital Manufacturingoption or derivativeSEC FORM 4 Code A—440,675filing
3 Apr 2023filed 11 May 2023Fathom Digital ManufacturingSEC FORM 4 Code A—235,027filing
8 Mar 2023filed 10 Mar 2023Fathom Digital ManufacturingSEC FORM 4 Sold$6,8065,672 at $1.20filing
14 Apr 2022filed 6 Dec 2022Fathom Digital ManufacturingSEC FORM 4 Code F$469K63,277 at $7.41filing
14 Apr 2022filed 1 Jun 2022Fathom Digital ManufacturingSEC FORM 4 Code F$319K43,082 at $7.41filing
14 Apr 2022filed 18 Apr 2022Fathom Digital ManufacturingSEC FORM 4 Code F$326K44,009 at $7.41filing
25 Feb 2022filed 20 Apr 2022Fathom Digital Manufacturingoption or derivativeSEC FORM 4 Code A—69,125filing
25 Feb 2022filed 20 Apr 2022Fathom Digital ManufacturingSEC FORM 4 Code A—33,746filing
25 Feb 2022filed 1 Mar 2022Fathom Digital Manufacturingoption or derivativeSEC FORM 4 Code A—69,125filing
25 Feb 2022filed 1 Mar 2022Fathom Digital ManufacturingSEC FORM 4 Code A—33,746filing
5 Dec 2016filed 14 Dec 2016AnalogicSEC FORM 4 Code F$63K695 at $90.95filing
5 Dec 2016filed 7 Dec 2016AnalogicSEC FORM 4 Code M—2,137filing
5 Dec 2016filed 7 Dec 2016AnalogicSEC FORM 4 Code F$51K566 at $90.95filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care1
Not placed4

Buys in green, sells in red, by the company’s sector.

Related people

Warren Nighan Jr.SVP Quality and Regulatory · SVP Quality and Regulatory at Angiodynamics, filing Form 4 there in the last year
Laura PiccininiSVP International · SVP International at Angiodynamics, filing Form 4 there in the last year
James C. ClemmerPresident and CEO · President and CEO at Angiodynamics, filing Form 4 there in the last year
Stephen A. TrowbridgeEVP and CFO · EVP and CFO at Angiodynamics, filing Form 4 there in the last year
Chad Thomas CampbellSVP/GM, Vascular Access · SVP/GM, Vascular Access at Angiodynamics, filing Form 4 there in the last year